You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,895,614


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,895,614
Title:Composition and method for treating neurological disease
Abstract: A method of administering amantadine is provided. The method comprises orally administering to a subject a pharmaceutical composition comprising amantadine, or a pharmaceutically acceptable salt thereof, and one or more excipients, wherein at least one of the excipients modifies release of the amantadine. A dose of the composition provides a mean change in amantadine plasma concentration as a function of time (dC/dT) that is less than 40% of the change in amantadine plasma concentration provided by a dose of the same quantity of an immediate release form of amantadine. The change in plasma concentration over time (dC/dT) is measured in a single dose human pharmacokinetic study in a defined time period of 0 to 4 hours after administration. The amantadine, or pharmaceutically acceptable salt thereof, is administered once daily at a dose of 300 to 500 mg per day.
Inventor(s): Went; Gregory T. (Mill Valley, CA), Fultz; Timothy J. (Pleasant Hill, CA), Porter; Seth (San Carlos, CA), Meyerson; Laurence R. (Las Vegas, NV), Burkoth; Timothy S. (Lake Bluff, IL)
Assignee: Adamas Pharmaceuticals, Inc. (Emeryville, CA)
Application Number:14/328,440
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,895,614
Patent Claim Types:
see list of patent claims
Composition; Compound; Device; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis of U.S. Patent 8,895,614

Introduction

When navigating the complex world of patents, understanding the scope and claims of a particular patent is crucial for inventors, researchers, and business professionals. This article will delve into the specifics of U.S. Patent 8,895,614, providing a comprehensive analysis of its scope, claims, and the broader patent landscape.

What is U.S. Patent 8,895,614?

To begin, it is essential to identify the subject matter of U.S. Patent 8,895,614. This patent, issued to Adamas Pharmaceuticals, pertains to compositions and methods for the treatment of neurological diseases, including Parkinson's disease[5].

Patent Scope

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims, which are the legally binding descriptions of the invention[3].

Metrics for Measuring Patent Scope

Research has identified simple metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can indicate the breadth of the patent and its potential impact on innovation. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Scope of U.S. Patent 8,895,614

The scope of U.S. Patent 8,895,614 is defined by its claims, which include both composition of matter claims and method claims. The composition of matter claims covers specific chemical compounds, while the method claims cover the processes for treating neurological diseases using these compounds. This dual approach ensures broad protection for the invention while also providing specificity in its application[5].

Patent Claims

Types of Claims

Patent claims can be categorized into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claims in U.S. Patent 8,895,614

The claims in U.S. Patent 8,895,614 are structured to provide comprehensive protection for Adamas Pharmaceuticals' invention. The independent claims outline the core aspects of the compositions and methods, while the dependent claims add additional limitations to narrow the scope and avoid potential infringement issues.

Importance of Claim Language

The language used in patent claims is critical. It must be precise and clear to avoid ambiguity and ensure that the scope of the patent is well-defined. The examination process often narrows the scope of patent claims to ensure clarity and validity[3].

Patent Examination Process

Overview

The patent examination process involves a thorough review of the patent application by the United States Patent and Trademark Office (USPTO) to ensure that the invention is novel, non-obvious, and useful.

Impact on Patent Scope

During the examination process, the scope of the patent claims may be adjusted. Broader claims may be narrowed to ensure they meet the criteria for patentability. This process can significantly impact the final scope of the patent, as seen in the case of U.S. Patent 8,895,614, where the claims were refined to ensure specificity and validity[3].

Patent Landscape

Global Patent System

The global patent system is complex and involves various international intellectual property offices. Tools like the Global Dossier and Common Citation Document (CCD) facilitate the search and analysis of patents across different jurisdictions[1].

International Implications

For a patent like U.S. Patent 8,895,614, it is important to consider its implications globally. Inventors and companies must search international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), to ensure their invention is novel and non-obvious on a global scale[1].

Searching and Analyzing Patents

Tools and Resources

Several tools and resources are available for searching and analyzing patents. The USPTO's Patent Public Search tool, Global Dossier, and Public Search Facility are essential resources. Additionally, Patent and Trademark Resource Centers (PTRCs) and the Electronic Official Gazette provide valuable information[1].

Example: Searching for U.S. Patent 8,895,614

To analyze U.S. Patent 8,895,614, one would use the Patent Public Search tool to locate the patent and review its claims, descriptions, and any cited prior art. The Global Dossier can be used to see the patent family and related applications filed in other jurisdictions.

Legal and Regulatory Considerations

Changes in Patent Laws

Changes in patent laws or their interpretation can significantly impact the value of patents. For instance, changes in the U.S. or other countries could diminish the value of U.S. Patent 8,895,614 if they affect the validity or scope of the patent claims[4].

Office Actions and Citations

Office actions and citations are crucial in understanding the patent landscape. Tools like the Common Citation Document (CCD) help in consolidating citation data from multiple offices, providing a comprehensive view of the prior art cited for a patent family[1].

Conclusion

Understanding the scope and claims of a U.S. patent, such as U.S. Patent 8,895,614, is vital for navigating the intellectual property landscape. Here are the key takeaways:

  • Patent Scope: Defined by the claims, which can be measured using metrics like independent claim length and count.
  • Claims: Independent and dependent claims work together to provide comprehensive protection.
  • Examination Process: Narrows the scope of claims to ensure clarity and validity.
  • Global Implications: Consideration of international patent databases is essential.
  • Tools and Resources: Utilize USPTO tools, Global Dossier, and PTRCs for thorough analysis.
  • Legal Considerations: Changes in patent laws and office actions can impact patent value.

Key Takeaways

  • Patent Scope Metrics: Independent claim length and count are key metrics.
  • Claim Structure: Independent and dependent claims define the invention.
  • Global Search: Use international databases to ensure novelty and non-obviousness.
  • Legal Impact: Changes in laws and office actions can affect patent value.
  • Tools and Resources: Utilize USPTO and international tools for comprehensive analysis.

FAQs

Q: What is the significance of independent claim length and count in measuring patent scope?

A: Independent claim length and count are metrics that help measure the breadth of a patent. Narrower claims are associated with a higher probability of grant and a shorter examination process[3].

Q: How does the patent examination process affect the scope of patent claims?

A: The examination process often narrows the scope of patent claims to ensure clarity and validity, making the claims more specific and reducing the risk of infringement[3].

Q: What tools are available for searching and analyzing patents globally?

A: Tools like the Global Dossier, Common Citation Document (CCD), and databases from international intellectual property offices such as the EPO, JPO, and WIPO are available for global patent searches[1].

Q: How can changes in patent laws impact the value of a patent?

A: Changes in patent laws or their interpretation can diminish the value of patents by affecting the validity or scope of the patent claims[4].

Q: What is the role of the USPTO's Patent Public Search tool in patent analysis?

A: The USPTO's Patent Public Search tool provides enhanced access to prior art, allowing users to search and analyze patents more effectively[1].

Sources

  1. USPTO: Search for patents - USPTO.
  2. Biospace: Adamas Pharmaceuticals Issued Six Additional U.S. Patents.
  3. SSRN: Patent Claims and Patent Scope.
  4. Public Now: ADAMAS PHARMACEUTICALS, INC.
  5. GlobeNewswire: Adamas Pharmaceuticals Issued Six Additional U.S. Patents.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,895,614

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Supernus Pharms GOCOVRI amantadine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208944-001 Aug 24, 2017 AB RX Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Supernus Pharms GOCOVRI amantadine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 208944-002 Aug 24, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
Supernus Pharms OSMOLEX ER amantadine hydrochloride TABLET, EXTENDED RELEASE;ORAL 209410-001 Feb 16, 2018 DISCN Yes No ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.